section name header
Index
ACE Inhibitors and Angiotensin II Receptor Blockers for Diabetics with Microalbuminuria
Administration
Adrenal Tumours
Aldosterone Receptor Antagonists Spironolactone and Eplerenone for Congestive Heart Failure
Antihypertensive Agents for Preventing Diabetic Kidney Disease
Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke
Association of Glycaemic Control and Complications of Type 2 Diabetes
Association of Systolic Blood Pressure and Complications of Type 2 Diabetes
Cardiology
Choice of Antihypertensive Drug in the Diabetic Patient from Prognostic Point of View
Comprehensive Treatment and Follow-Up of Type 2 Diabetes
Definition and Diagnosis of Dyslipidaemias
Diabetic Ketoacidosis
Diagnostic Classification of Acute Coronary Syndromes
Efficacy and Safety of Cholesterol Lowering by Statins
Ezetimibe for the Prevention of Cardiovascular Disease
Fibrates for Primary Prevention of Cardiovascular Disease
Garlic and Cardiovascular Risk Factors
Glucagon-Like Peptide Analogues (GLP-1 Analogues) for Type 2 Diabetes
Glycaemic Control for Slowing the Progression of Microvascular Complications in Diabetes Mellitus
Insulin Added on Metformin in Type 2 Diabetes
Insulin Therapy in Type 2 Diabetes
Intensive Versus Moderate Statin Therapy
Internal medicine
List of Abbreviations
Low-Dose Aspirin for Prevention of Vascular Events in Type 2 Diabetes
Male Hypogonadism and Hormone Replacement - Related Resources
Menopausal Hormone Therapy and the Risk of Stroke
Neurology
Obesity and Waist-to-Hip-Ratio and Risk of Myocardial Infarction
Oral Antidiabetic Drugs and GLP-1 Analogues
Oral Antidiabetic Drugs and GLP-1 Analogues in the Treatment of Type 2 Diabetes - Related Resources
Osteoporosis
Pcsk9 Inhibitors for Prevention of Cardiovascular Disease
Prevention of Type 2 Diabetes in Persons at Increased Risk for the Development of T2d
Rosiglitazone for Type 2 Diabetes Mellitus
Sglt-2 Inhibitors and GLP-1 Agonists for Diabetes and Chronic Kidney Disease
Sglt-2 Inhibitors in Type 2 Diabetes
Statins for Improving Renal Outcomes
Statins for the Primary Prevention of Cardiovascular Disease
Steroid Doping
Sulphonylurea for Type 2 Diabetes
Surgery for Morbid Obesity
Transdermal and Oral Hormone Replacement Therapy and the Risk of Stroke
Treatment of Dyslipidaemias
Treatment of Obesity - Related Resources